V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260014801 | 260014824 | 1.71 | null | Curative (C) | 2017-09-18 | 2017-12-04 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 260023349 | CARBOPLATIN + ETOPOSIDE |
| 260014802 | 260014824 | 1.76 | 68.8 | Curative (C) | 2017-08-19 | 2017-10-08 | IPO | N | N | 260023349 | METHOTREXATE HIGH DOSE |
| 260014803 | 260014824 | 1.66 | 61.2 | Curative (C) | 2016-08-09 | 2016-08-22 | CYCLOPHOSPHAMIDE | N | N | 260023349 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014804 | 260010196 | 1.7 | 77.3 | null | null | 2018-02-18 | Trastuzumab Subcutaneous | N | N | 260025486 | NIVOLUMAB |
| 260014805 | 260010198 | 1.89 | 106.2 | Palliative (P) | 2017-08-29 | 2017-09-02 | STS Rhabdomyosarcoma RMS 2005 VA | 02 | N | 260025887 | CARBOPLATIN + VINORELBINE |
| 260014806 | 260018259 | 1.81 | 67.4 | Curative (C) | 2018-04-10 | 2018-04-20 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | null | 260026055 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260014807 | 260018259 | 1.86 | null | Palliative (P) | null | 2015-12-07 | POMB | N | N | 260026055 | CISPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260014808 | 260018259 | 1.61 | 66.3 | Curative (C) | 2018-09-12 | 2018-09-17 | Cytarabine HD + Methotrexate HD | 02 | N | 260026055 | FEC |
| 260014809 | 260010200 | 1.77 | 76 | Curative (C) | null | 2016-03-28 | VIP | N | N | 260026625 | BENDAMUSTINE + OBINUTUZUMAB |
| 260014810 | 260010200 | 1.73 | 77.3 | Curative (C) | 2019-03-11 | 2019-05-06 | PAC-PLAT | N | N | 260026625 | IFOSFAMIDE + PACLITAXEL |
| 260014811 | 260010200 | 1.7 | 82.4 | Curative (C) | 2016-02-05 | 2016-02-07 | Cisplatin | N | null | 260026625 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 260014812 | 260010202 | 1.64 | 96 | Disease modification (D) | 2018-11-29 | 2018-11-30 | CARBO + THIOTEPA + TOPOTECAN | N | N | 260028496 | POMB |
| 260014813 | 260010204 | 1.63 | 58.3 | Curative (C) | 2016-06-21 | 2016-07-24 | CHOP - 21 days | N | N | 260028507 | MELPHALAN |
| 260014814 | 260010205 | 1.84 | 106 | null | 2016-04-24 | 2016-04-24 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 260029516 | CISPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260014815 | 260010206 | 1.7 | 46 | Palliative (P) | 2018-08-02 | 2018-08-12 | IVA | N | N | 260029639 | BLEOMYCIN |
| 260014816 | 260010208 | 1.65 | 117 | Disease modification (D) | 2014-11-13 | 2014-11-17 | BLEOMYCIN + VINCRISTINE | N | N | 260029800 | TRASTUZUMAB |
| 260014817 | 260010209 | 1.84 | 62 | Curative (C) | 2016-06-29 | 2016-08-03 | BLEOMYCIN | N | N | 260029897 | ACE (GERM CELL) |
| 260014818 | 260010211 | 1.65 | 53.8 | Disease modification (D) | 2017-07-03 | 2017-07-03 | BLEOMYCIN | 2 | N | 260030130 | CARBO + THIOTEPA + TOPOTECAN |
| 260014819 | 260010212 | 1.77 | 76.4 | Palliative (P) | 2019-09-20 | 2019-09-20 | CARBOPLATIN + PACLITAXEL | N | N | 260000136 | PEMBROLIZUMAB |
| 260014820 | 260010213 | 1.66 | 70 | Curative (C) | 2017-02-08 | 2017-02-17 | Cytarabine HD + Methotrexate HD | 2 | N | 260001122 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260014821 | 260010214 | 1.81 | 81.5 | Curative (C) | 2015-04-28 | 2015-04-28 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | N | 260001891 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260014822 | 260010215 | 1.65 | 71.4 | Curative (C) | 2019-01-04 | 2019-01-05 | R-GEM-P | 02 | N | 260003454 | BEACOPP |
| 260014823 | 260010217 | 1.69 | 47 | Curative (C) | 2017-12-28 | 2018-01-05 | CARBO + THIOTEPA + TOPOTECAN | N | N | 260006100 | ACE (GERM CELL) |
| 260014824 | 260010217 | 1.73 | 74 | null | 2016-11-30 | 2016-11-30 | Cyclophosphamide PO +Vinorelbine IV | 02 | N | 260006100 | BENDAMUSTINE + OBINUTUZUMAB |
| 260014825 | 260010221 | 1.76 | 65.2 | Curative (C) | 2018-04-23 | 2018-04-24 | METHOTREXATE | N | N | 260006806 | CARBOPLATIN + PACLITAXEL |
| 260014826 | 260010221 | 1.79 | 66 | Palliative (P) | 2019-01-19 | 2019-02-02 | VIDE | N | N | 260006806 | VINBLASTINE |
| 260014827 | 260010224 | 1.67 | 60.2 | Curative (C) | 2017-06-18 | 2017-07-07 | Docetaxel | N | null | 260007145 | DOCETAXEL |
| 260014828 | 260010226 | 1.82 | 96 | Neo-adjuvant (N) | 2014-03-11 | 2014-03-30 | Obinutuzumab | N | N | 260007252 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL |
| 260014829 | 260010227 | 1.77 | 77 | null | null | 2015-09-01 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | null | null | 260007814 | BLEOMYCIN |
| 260014830 | 260018265 | 1.84 | 131.1 | Palliative (P) | 2014-05-12 | 2014-05-12 | Cyclophosphamide PO +Vinorelbine IV | N | N | 260007854 | DOCETAXEL + GEMCITABINE |
| 260014831 | 260010229 | 1.9 | 90.5 | Curative (C) | 2018-03-09 | 2018-03-11 | Carboplatin + Etoposide IV 3 day | 02 | N | 260008957 | IFOSFAMIDE + PACLITAXEL |
| 260014832 | 260010230 | 1.77 | 83 | Palliative (P) | 2018-07-10 | 2018-10-09 | POMB | N | N | 260008957 | ACE (GERM CELL) |
| 260014833 | 260010233 | 0 | null | Curative (C) | 2017-06-25 | 2017-06-30 | ICE | N | null | 260010715 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014834 | 260010234 | 1.71 | 47.3 | Curative (C) | 2016-12-13 | 2017-09-14 | Capecitabine 35days + RT | N | N | 260013467 | METHOTREXATE |
| 260014835 | 260010236 | 1.7 | 81.2 | Curative (C) | 2016-12-22 | 2017-01-19 | VIP | N | N | 260014181 | BLEOMYCIN + CISPLATIN + VINBLASTINE |
| 260014836 | 260010236 | 1.8 | 72.4 | Curative (C) | 2018-08-01 | 2018-08-06 | BLEOMYCIN + VINCRISTINE | N | N | 260014181 | CARBO + THIOTEPA + TOPOTECAN |
| 260014837 | 260010237 | 1.54 | 52 | Adjuvant (A) | 2019-04-03 | 2019-04-05 | Docetaxel 100mg/m2 (21 day) | N | N | 260015405 | CISPLATIN + RT |
| 260014838 | 260014846 | 1.69 | 88.3 | Adjuvant (A) | 2017-02-26 | 2017-05-31 | Pazopanib | 02 | N | 260015436 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260014839 | 260014846 | 1.83 | 71.7 | Not known (9) | 2013-12-25 | 2013-12-26 | ACE (germ cell) | 2 | null | 260015436 | CAPECITABINE + RT |
| 260014840 | 260014846 | 1.72 | 85.1 | Curative (C) | 2017-04-09 | 2017-04-16 | CISPLATIN + IFOSFAMIDE + PACLITAXEL | N | N | 260015436 | CYCLOPHOSPHAMIDE |
| 260014841 | 260010238 | 1.68 | null | null | 2018-10-04 | 2018-10-04 | Docetaxel + Trastuzumab (Maint) | N | N | 260017117 | ICE |
| 260014842 | 260010239 | 1.87 | null | Curative (C) | 2018-08-21 | 2018-09-11 | CYCLOPHOSPHAMIDE | N | N | 260017408 | DOCETAXEL + TRASTUZUMAB |
| 260014843 | 260018840 | 1.77 | 74 | Curative (C) | 2014-08-02 | 2014-09-05 | VINCRISTINE | N | N | 260017408 | FMD |
| 260014844 | 260018840 | 1.82 | 90 | Curative (C) | 2019-07-21 | 2019-08-15 | POMB | N | N | 260017408 | VINBLASTINE |
| 260014845 | 260018840 | 1.64 | 86 | Palliative (P) | 2018-04-01 | 2018-04-01 | CHOP - 21 days | N | N | 260017408 | ICE |
| 260014846 | 260010241 | 0 | null | Palliative (P) | null | 2017-02-26 | TRASTUZUMAB | null | null | 260019019 | CARBOPLATIN + PACLITAXEL |
| 260014847 | 260010242 | 1.72 | 64 | Curative (C) | 2019-11-18 | 2019-11-25 | Gemcitabine + Oxaliplatin | N | N | 260019019 | BLEOMYCIN + VINCRISTINE |
| 260014848 | 260010247 | 1.72 | 55.6 | Palliative (P) | 2016-01-17 | 2016-01-17 | IFOSFAMIDE + PACLITAXEL | 02 | N | 260022492 | BOP |
| 260014849 | 260014850 | 1.69 | 98.9 | Curative (C) | 2019-02-01 | 2019-02-18 | GEMCITABINE + TIP | N | N | 260022492 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014850 | 260010249 | 1.74 | 75 | Disease modification (D) | 2013-12-08 | 2013-12-15 | POMB | N | null | 260014077 | BLEOMYCIN + CISPLATIN + VINCRISTINE |